Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics

Aristolochic acid (AA), mainly derived from herbal and plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced ne...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of biological sciences Vol. 18; no. 5; pp. 2003 - 2017
Main Authors Zhang, Qian, Luo, Piao, Chen, Jiayun, Yang, Chuanbin, Xia, Fei, Zhang, Junzhe, Tang, Huan, Liu, Dandan, Gu, Liwei, Shi, Qiaoli, He, Xueling, Yang, Tong, Wang, Jigang
Format Journal Article
LanguageEnglish
Published Australia Ivyspring International Publisher Pty Ltd 01.01.2022
Ivyspring International Publisher
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aristolochic acid (AA), mainly derived from herbal and plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.
AbstractList Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.
Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.
Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.
Aristolochic acid (AA), mainly derived from herbal and plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a rapidly progressive tubulointerstitial nephritis and urothelial cancer caused by AA. However, the targeting molecular mechanisms of AAs-induced nephrotoxicity are largely unclear. This study aims to dissect targeting molecular mechanisms of AA-induced nephrotoxicity. Activity-based protein profiling (ABPP) in combination with cellular thermal shift assay (CETSA) was performed to identify the AAs binding target proteins. Our data indicated that several key enzymes in the metabolic process and mitochondrial respiration including IDH2 and MDH2 (Krebs cycle), PKM and LDH (aerobic respiration), FASN (fatty acid beta-oxidation), HK2 (glucose metabolism), and ATP synthase were identified as directly binding targets of AAs. Metabolomics and oxygen consumption rate (OCR) experiments further confirmed that AAs targeting proteins disrupted metabolic biosynthesis processes and impaired mitochondrial functions. Ultimately, AAs induced renal cells apoptosis by disturbing various biological processes. Cumulatively, AAs may directly bind to key proteins involved in the metabolic process and mitochondrial homeostasis, and finally induce aristolochic acid nephropathy. Our findings provide novel insight into underlying mechanisms of AAs-induced kidney toxicity, which may help to develop therapeutic strategies for AAN.
Author Zhang, Qian
He, Xueling
Luo, Piao
Chen, Jiayun
Gu, Liwei
Yang, Chuanbin
Tang, Huan
Yang, Tong
Xia, Fei
Zhang, Junzhe
Liu, Dandan
Shi, Qiaoli
Wang, Jigang
AuthorAffiliation 1 Artemisinin research center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
6 Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong 524037, China
4 Department of Urology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, China
3 School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
5 Center for Reproductive Medicine, Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan 523125, China
2 School of Chinese Materia Medica, and State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
7 Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
AuthorAffiliation_xml – name: 4 Department of Urology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, China
– name: 6 Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong 524037, China
– name: 2 School of Chinese Materia Medica, and State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
– name: 3 School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China
– name: 7 Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
– name: 5 Center for Reproductive Medicine, Dongguan Maternal and Child Health Care Hospital, Southern Medical University, Dongguan 523125, China
– name: 1 Artemisinin research center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
Author_xml – sequence: 1
  givenname: Qian
  surname: Zhang
  fullname: Zhang, Qian
– sequence: 2
  givenname: Piao
  surname: Luo
  fullname: Luo, Piao
– sequence: 3
  givenname: Jiayun
  surname: Chen
  fullname: Chen, Jiayun
– sequence: 4
  givenname: Chuanbin
  surname: Yang
  fullname: Yang, Chuanbin
– sequence: 5
  givenname: Fei
  surname: Xia
  fullname: Xia, Fei
– sequence: 6
  givenname: Junzhe
  surname: Zhang
  fullname: Zhang, Junzhe
– sequence: 7
  givenname: Huan
  surname: Tang
  fullname: Tang, Huan
– sequence: 8
  givenname: Dandan
  surname: Liu
  fullname: Liu, Dandan
– sequence: 9
  givenname: Liwei
  surname: Gu
  fullname: Gu, Liwei
– sequence: 10
  givenname: Qiaoli
  surname: Shi
  fullname: Shi, Qiaoli
– sequence: 11
  givenname: Xueling
  surname: He
  fullname: He, Xueling
– sequence: 12
  givenname: Tong
  surname: Yang
  fullname: Yang, Tong
– sequence: 13
  givenname: Jigang
  surname: Wang
  fullname: Wang, Jigang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35342337$$D View this record in MEDLINE/PubMed
BookMark eNptkttq3DAQhkVJaA7tTR-gCHoTCk4kWT7dFJZNmxaS9qJ7LyR5vNZiS1tJXrqv0yetnBNJyJUGzTf_P8PMCTqwzgJCHyg5r2hBLsxGhfOyKWn9Bh1TzpuMsbo-eBIfoZMQNoTkZVGTt-goL3LO8rw6Rv8uTQigo3EWuw6vpF9DNHaNb9wAehqkxzege2lNGMNMLLwJ0Q1O90bjhTZtZmw7aWjxT9j23kX312gT93hnJJZ46UZlbMpegnZ254bp1up39DLCej8rLnsY3TZVghuNDljaNnlGqZLL_PEOHXZyCPD-_j1Fq29fV8vv2fWvqx_LxXWmecViVhJSF63kigHXTaXzti5VpbqWS8oYVwoUgOZUdVSTihJWdnUDFSiq85JCfoq-3MluJzVCq8GmHgex9WaUfi-cNOJ5xpperN1O1E1eMFYkgbN7Ae_-TBCiGE3QMAzSgpuCYCXnyYkWPKGfXqAbN3mbppspWtC6rEiiPj7t6LGVh-0l4PMdoL0LwUP3iFAi5tMQ82mI29NIMHkBpzXJeRtpGjO8VvIfxADBpg
CitedBy_id crossref_primary_10_1016_S1875_5364_24_60608_4
crossref_primary_10_1016_j_phrs_2024_107388
crossref_primary_10_3390_app15052783
crossref_primary_10_1002_jat_4743
crossref_primary_10_1016_j_jhazmat_2024_136760
crossref_primary_10_1007_s11130_025_01332_9
crossref_primary_10_1265_ehpm_23_00245
crossref_primary_10_1016_j_taap_2024_116992
crossref_primary_10_59717_j_xinn_med_2024_100066
crossref_primary_10_1016_j_toxlet_2024_08_001
crossref_primary_10_3389_fnut_2025_1518014
crossref_primary_10_1039_D3SC04826H
crossref_primary_10_3390_app14177961
crossref_primary_10_1002_ijch_202300179
crossref_primary_10_1016_j_envint_2024_109234
crossref_primary_10_1016_j_jep_2024_118116
crossref_primary_10_3390_metabo13050609
crossref_primary_10_1152_ajprenal_00139_2024
crossref_primary_10_3389_fphar_2022_940791
crossref_primary_10_1093_toxres_tfad020
crossref_primary_10_1055_a_2517_9234
crossref_primary_10_3390_ijms252011289
crossref_primary_10_1016_j_envpol_2024_123949
crossref_primary_10_3892_etm_2023_12232
crossref_primary_10_15212_AMM_2024_0023
crossref_primary_10_1093_pcmedi_pbac023
crossref_primary_10_1080_10408444_2023_2168178
crossref_primary_10_1016_j_fitote_2024_106297
crossref_primary_10_1016_j_toxlet_2024_11_003
crossref_primary_10_1016_j_cbi_2024_111269
ContentType Journal Article
Copyright The author(s).
2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The author(s) 2022
Copyright_xml – notice: The author(s).
– notice: 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The author(s) 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7U9
8FD
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FR3
H94
M7N
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
RC3
7X8
5PM
DOI 10.7150/ijbs.69618
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Virology and AIDS Abstracts
Technology Research Database
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Virology and AIDS Abstracts
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Genetics Abstracts
Biotechnology Research Abstracts
ProQuest One Academic UKI Edition
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Engineering Research Database
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central (New)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1449-2288
EndPage 2017
ExternalDocumentID PMC8935225
35342337
10_7150_ijbs_69618
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
29J
2WC
4.4
53G
5GY
5VS
AAYXX
ACGFO
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
C1A
CCPQU
CITATION
DIK
DU5
E3Z
EBS
EJD
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
OVT
PGMZT
PHGZM
PHGZT
PIMPY
RNS
RPM
TR2
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7U9
8FD
ABUWG
AZQEC
C1K
DWQXO
FR3
H94
M7N
P64
PKEHL
PQEST
PQQKQ
PQUKI
RC3
7X8
5PM
ID FETCH-LOGICAL-c472t-60085da4b2e4c97c3d86b7bfd4a1224bbebeec41bf1c071026f89e7eb1c361e3
IEDL.DBID M48
ISSN 1449-2288
IngestDate Thu Aug 21 14:32:03 EDT 2025
Fri Jul 11 15:21:22 EDT 2025
Mon Jun 30 11:56:01 EDT 2025
Thu Jan 02 22:54:17 EST 2025
Tue Jul 01 04:07:43 EDT 2025
Thu Apr 24 23:12:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords apoptosis
chemical proteomics
metabolism
mitochondrial dysfunction
Aristolochic acid nephropathy
Language English
License The author(s).
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-60085da4b2e4c97c3d86b7bfd4a1224bbebeec41bf1c071026f89e7eb1c361e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
Competing Interests: The authors have declared that no competing interest exists.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.7150/ijbs.69618
PMID 35342337
PQID 2641518670
PQPubID 2046459
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8935225
proquest_miscellaneous_2644361154
proquest_journals_2641518670
pubmed_primary_35342337
crossref_primary_10_7150_ijbs_69618
crossref_citationtrail_10_7150_ijbs_69618
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Sydney
PublicationTitle International journal of biological sciences
PublicationTitleAlternate Int J Biol Sci
PublicationYear 2022
Publisher Ivyspring International Publisher Pty Ltd
Ivyspring International Publisher
Publisher_xml – name: Ivyspring International Publisher Pty Ltd
– name: Ivyspring International Publisher
SSID ssj0036580
Score 2.4675007
Snippet Aristolochic acid (AA), mainly derived from herbal and plants, was listed as a human carcinogen class I in 2002. Aristolochic acid nephropathy (AAN) is a...
Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid...
Aristolochic acid (AA), mainly derived from herbal Aristolochia and Asarum plants, was listed as a human carcinogen class I in 2002. Aristolochic acid...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2003
SubjectTerms Aerobic respiration
Apoptosis
Aristolochic acid
Aristolochic Acids - toxicity
ATP synthase
Binding
Biological activity
Biosynthesis
Carcinogens
Dehydrogenases
Electron transport
Enzymes
Experiments
Fatty acids
Female
Glucose metabolism
Homeostasis
Humans
Kidney
Kidney diseases
Kidney Diseases - chemically induced
Kinases
Krebs cycle
Labeling
Localization
Male
Metabolism
Metabolites
Metabolomics
Mitochondria
Molecular modelling
Natural products
Nephritis
Nephropathy
Oxidation
Oxygen consumption
Proteins
Proteomics
Research Paper
Respiration
Toxicity
Tricarboxylic acid cycle
Urothelial cancer
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFD5oi-BL8W60yoi--DA2m8zOZJ9k7YUi7CKyQt_C3EIjbVJNWuzf8Zd6zmSydlV8CmQOSeA7Oeeby_kOwBudVq6olOBSS8GF0J4XJp3xymG-z3yaZ6Gdz2Ipj7-IjyfTk7jg1sVjlWNMDIHatZbWyPcwcWNyKqRK319849Q1inZXYwuN27CNIbjAydf2h8Plp89jLM4xv6aDKKlC5rNXfzXdO0lNTjbT0F_c8s8jkjdyztE92Ilkkc0HdO_DLd88gDtD-8jrh_DzgDbTQ2ECayu2Coe6MRWxxdjzli08VfbW3XlHFvMgJIDp67S2bG5rx3FGjtg6tvQIatu3P2qLtJxd1ZpphrEC5804ekCz5qvopCwK2l7TE0lvoA1aD1Td3DHdOHxnj551Fm48gtXR4Wr_mMeeC9wKlfVcEgdzWpjMCztTNneFNMpUTmjagzMGQfdWTEw1sYGdyKqYeYUR3-Zy4vPHsNW0jX8KTCrvRZ5VyC-t0MoUVFM3NXjFEFIIk8DbEYHSRj1yaotxVuK8hNAqCa0yoJXA67XtxaDC8U-r3RHIMv6JXfnbbxJ4tR7Gf4g2RnTj28tgI_DrkU0m8GTAff2afEoaiblKQG14xNqA9Lk3R5r6NOh0IxVEdjt99v_Peg53MyqpCMs6u7DVf7_0L5Do9OZl9OZfS9sFzw
  priority: 102
  providerName: ProQuest
Title Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics
URI https://www.ncbi.nlm.nih.gov/pubmed/35342337
https://www.proquest.com/docview/2641518670
https://www.proquest.com/docview/2644361154
https://pubmed.ncbi.nlm.nih.gov/PMC8935225
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB5RUCsuVemDulC0VXvpwaljb3adE0pLEEJKVFVB4mbtrtfCKNgtNohc-mP6SzuzfojXiYstecd25G_W803W8w3AFxVkaZxJ7gsluM-5sn6sg7GfpRjvQxtEoWvnM5uLoxN-fDo6XYOuf2f7AKtHUzvqJ3VyuRzc_Fnt44RH_jqQyGe-5ee6GghqXfIMNjAiSZqgM96vJkQYZYNGmvSe_Sa8iEakgUdt0G_HpQdk8_43k7eC0OEreNmyRzZp4N6CNVu8hudNP8nVG_h3QKvrrlKBlRlbuK-8MTaxWdcEl80slfrm1UVFFhOnLIDx7Cw3bGLy1McUHcFO2dwiymVd3uQGeTq7zhVTDF8emEjj6AGl0det17JW4XZFVyQBgtKJP1C5c8VUkeI9a3S1pTvwFhaH08WPI79twuAbLsPaF0TKUsV1aLkZSxOlsdBSZylXtCinNXqBNXyos6FxdEVk8dhKDAEmEkMbvYP1oizse2BCWsujMEPCabiSOqYiu5HGPb5TYq49-NohkJhWoJz6ZCwTTFQIuISASxxwHnzubX83shyPWu12QCadZyXIAJHlxEIGHnzqh3FS0UqJKmx55Ww4_nqklx5sN7j3t-kcxgN5xyN6AxLsvjtS5GdOuBu5IdLd0Ycnn7kDmyGVX7i_gHZhvb68sh-RFNV6Dza-T-c_f-05z6ft3-l_EmoWxw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAguiDeGAouAAwe3jr3ZdQ4IBdIqpU2EUJB6s_Zl1ajYBaeF_B3u_Edm1nYggLj1ZMk78kPz7Tx2d74BeKai3Ka55KFQgoecKxemOhqGuUV_H7soiX07n-lMTD7wt0eDow340dXC0LHKziZ6Q20rQ2vkO-i40TmlQkavTj-H1DWKdle7FhoNLA7c8iumbPXL_THq93kc7-3O30zCtqtAaLiMF6GgKMMqrmPHzVCaxKZCS51brmiXSWv8LWd4X-d94_2vyNOhk2jTTCL6LsHHXoJNnmAm04PN17uzd-8705-gO48aDlSJgdZO8VHX24J6qqx7vb9C2T9PZP7m4vauw7U2NmWjBkw3YMOVN-Fy061yeQu-j2nv3tdBsCpnc3-GHD0fm3YtdtnUUSFxUX-qSWLkeQvQWx4Xho1MYcOitAgly2YOMVQtqm-FwSyAnReKKYamCdN0HB1Tkn7ezgnW8ucu6YlEb1B5agkqpq6ZKi2-c4FAPvE3bsP8IpRxB3plVbp7wIR0jidxjuGs4UrqlEr4BhqvaLFSrgN40WkgMy39OXXhOMkwDSJtZaStzGsrgKcr2dOG9OOfUludIrN24tfZL5gG8GQ1jFOW9mFU6aozL4PwIR6kAO42el-9JhkQJWMiA5BriFgJEB34-khZHHtacIw8MZge3P__Zz2GK5P59DA73J8dPICrMVVz-BWlLegtvpy5hxhjLfSjFtkMsgueSz8BXvRDYg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrUBcEP8EChgBBw7pZhOvnT0gtLBdtZRdVWiReotsx1GD2qQlaWFfh7fg7ZhxkoUFxK2nSPEoP5rxfDO25xuAFyrI0jiT3BdKcJ9zZf1YByM_SxHvQxtEoWvnM5uL3U_8_eHwcAN-dLUwdKyy84nOUaeloTXyPgI3glMsZNDP2mMRB5Ppm9MznzpI0U5r106jMZF9u_yK6Vv1em-Cun4ZhtOdxbtdv-0w4Bsuw9oXFHGkiuvQcjOSJkpjoaXOUq5ox0lr_EVr-EBnA-OwWGTxyEr0byYSAxvhY6_ApsSkKOjB5tud-cHHDgYihPag4UOVGHT188-62hbUX2UdAf8Ka_88nfkb3E1vwo02TmXjxrBuwYYtbsPVpnPl8g58n9A-vquJYGXGFu48OaIgm3XtdtnMUlFxXp1UJDF2HAaInEe5YWOTp35epGhWKZtbtKeyLr_lBjMCdpErphi6KUzZcXRCCftFOz9Yy6W7pCcS1UHpaCaosLpiqkjxnTUa9bG7cRcWl6GMe9ArysI-ACaktTwKMwxtDVdSx1TON9R4Re8Vc-3Bq04DiWmp0Kkjx3GCKRFpKyFtJU5bHjxfyZ42BCD_lNrqFJm0TqBKfpmsB89Wwzh9aU9GFbY8dzIcvx4DWQ_uN3pfvSYaEj1jJD2QaxaxEiBq8PWRIj9yFOEYhWJgPXz4_896CtdwDiUf9ub7j-B6SIUdbnFpC3r1l3P7GMOtWj9pDZtBcslT6SfSdEeX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dissection+of+Targeting+Molecular+Mechanisms+of+Aristolochic+Acid-induced+Nephrotoxicity+via+a+Combined+Deconvolution+Strategy+of+Chemoproteomics+and+Metabolomics&rft.jtitle=International+journal+of+biological+sciences&rft.au=Zhang%2C+Qian&rft.au=Luo%2C+Piao&rft.au=Chen%2C+Jiayun&rft.au=Yang%2C+Chuanbin&rft.date=2022-01-01&rft.pub=Ivyspring+International+Publisher&rft.eissn=1449-2288&rft.volume=18&rft.issue=5&rft.spage=2003&rft.epage=2017&rft_id=info:doi/10.7150%2Fijbs.69618&rft_id=info%3Apmid%2F35342337&rft.externalDocID=PMC8935225
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1449-2288&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1449-2288&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1449-2288&client=summon